Deere & Company’s Ligand Pharmaceuticals LGND Stock Holding History

Deere & Company’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,820	Closed	-$258K	–	1093
2015 Q4	$258K	Buy	+3,820	New	+$236K	0.02%	749
2015 Q3	–	Sell	-4,815	Closed	-$303K	–	993
2015 Q2	$303K	Hold	4,815	–	–	0.02%	769
2015 Q1	$232K	Sell	4,815 -7,169	-60%	-$275K	0.01%	819
2014 Q4	$398K	Hold	11,984	–	–	0.02%	713
2014 Q3	$351K	Hold	11,984	–	–	0.02%	758
2014 Q2	$466K	Buy	11,984 +7,154	+148%	+$290K	0.03%	658
2014 Q1	$203K	Sell	4,830 -21,594	-82%	-$900K	0.01%	839
2013 Q4	$867K	Hold	26,424	–	–	0.04%	459
2013 Q3	$713K	Sell	26,424 -9,637	-27%	-$271K	0.04%	490
2013 Q2	$841K	Buy	+36,061	New	+$649K	0.05%	368

Other funds holding LGND

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Deere & Company's LGND Position: Q1 2016 in Review

Deere & Company sold out of Ligand Pharmaceuticals (LGND) in Q1 2016, closing a stake of 3,820 shares — an estimated $258K sold.

Deere & Company first reported a position in LGND in Q2 2013 and held it in 10 quarters. The position peaked at $867K in Q4 2013. 251 funds tracked by Wall St. Rank hold LGND as of Q1 2016.

Deere & Company reported no remaining Ligand Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Deere & Company sold 3,820 Ligand Pharmaceuticals shares in Q1 2016, an estimated $258K.
Deere & Company first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Deere & Company's Ligand Pharmaceuticals position peaked at $867K in Q4 2013.
251 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.